KLC4 is a kinesin-1 light chain subunit that supports microtubule-based intracellular transport in neurons, where it is required for stabilization of nascent axon branches, proper microtubule dynamics, endosomal transport, and the patterning of central versus peripheral axonal compartments (PMID:36222498). Its role in kinesin-1-mediated transport is conserved: human KLC4 functionally replaces C. elegans klc-2, and a hereditary spastic paraplegia-associated variant introduced into this humanized background causes nuclear migration defects and lethality, directly linking the variant to loss of KLC4 transport function (PMID:37565267). Consistent with this, a homozygous truncating deletion in KLC4 segregates with hereditary spastic paraplegia in a consanguineous family, establishing KLC4 as a causative gene for this neurodegenerative disorder (PMID:26423925). Beyond its neuronal transport role, KLC4 has been implicated in cancer cell biology: its loss triggers mitochondrial calcium overload, impaired respiration, elevated ROS, and apoptosis (PMID:29717133), and it acts upstream of the checkpoint kinase CHK2 in the DNA damage response, with SETD3-driven downregulation of KLC4 promoting radiosensitization (PMID:32457423, PMID:31235251).